Apparent loss and hypertrophy of interneurons in a mouse model of neuronalceroid lipofuscinosis: Evidence for partial response to insulin-like growth factor-1 treatment
Jd. Cooper et al., Apparent loss and hypertrophy of interneurons in a mouse model of neuronalceroid lipofuscinosis: Evidence for partial response to insulin-like growth factor-1 treatment, J NEUROSC, 19(7), 1999, pp. 2556-2567
The neuronal ceroid lipofuscinoses (NCL) are progressive neurodegenerative
disorders with onset from infancy to adulthood that are manifested by blind
ness, seizures, and dementia. In NCL, lysosomes accumulate autofluorescent
proteolipid in the brain and other tissues. The mnd/mnd mutant mouse was fi
rst characterized as exhibiting adult-onset upper and lower motor neuron de
generation, but closer examination revealed early, widespread pathology sim
ilar to that seen in NCL. We used the autofluorescent properties of accumul
ated storage material to map which CNS neuronal populations in the mnd/mnd
mouse show NCL-like pathological changes. Pronounced, early accumulation of
autofluorescent lipopigment was found in subpopulations of GABAergic neuro
ns, including interneurons in the cortex and hippocampus. Staining for phen
otypic markers normally present in these neurons revealed progressive loss
of staining in the cortex and hippocampus of mnd/mnd mice, with pronounced
hypertrophy of remaining detectable interneurons. In contrast, even in aged
mutant mice, many hippocampal interneurons retained staining for glutamic
acid decarboxylase. Treatment with insulin-like growth factor-1 partially r
estored interneuronal number and reduced hypertrophy in some subregions. Th
ese results provide the first evidence for the involvement of interneurons
in a mouse model of NCL. Moreover, our findings suggest that at least some
populations of these neurons persist in a growth factor-responsive state.